The “Normothermic” Osborn Wave Induced by Severe Hypercalcemia

Por Otero, Javier, Lenihan, Daniel J.
Publicado em 2000

Overview and Management of Cardiac Adverse Events Associated With Tyrosine Kinase Inhibitors

Por Lenihan, Daniel J., Kowey, Peter R.
Publicado em 2013

In Reply

Por Lenihan, Daniel J., Kowey, Peter R.
Publicado em 2014

Cancer Therapy–Induced Cardiotoxicity: Basic Mechanisms and Potential Cardioprotective Therapies

Por Hahn, Virginia Shalkey, Lenihan, Daniel J., Ky, Bonnie
Publicado em 2014

Anti-Vascular Endothelial Growth Factor Therapies and Cardiovascular Toxicity: What Are the Important Clinical Markers to Target?

Por Vaklavas, Christos, Lenihan, Daniel, Kurzrock, Razelle, Tsimberidou, Apostolia Maria
Publicado em 2010

Cardiovascular Toxicity Profiles of Vascular-Disrupting Agents

Por Subbiah, Ishwaria M., Lenihan, Daniel J., Tsimberidou, Apostolia M.
Publicado em 2011

Cancer and Cardiovascular Disease: The Complex Labyrinth

Por Dent, Susan, Liu, Peter, Brezden-Masley, Christine, Lenihan, Daniel
Publicado no J Oncol (2015)

Dextrocardia: An Incidental Finding

Por Yusuf, Syed Wamique, Durand, Jean Bernard, Lenihan, Daniel J., Swafford, Joseph
Publicado em 2009

Cancer and Cardiovascular Disease

Por Yusuf, Syed Wamique, Cipolla, Carlo, Durand, Jean-Bernard, Lenihan, Daniel J.
Publicado em 2011

Myocardial Perfusion Imaging and Cardiovascular Outcomes in a Cancer Population

Por Chandra, Shalabh, Lenihan, Daniel J., Wei, Wei, Yusuf, Syed Wamique, Tong, Ann T.
Publicado em 2009

Exercise Intervention for Cancer Survivors with Heart Failure: Two Case Reports

Por Hughes, Daniel C., Lenihan, Daniel J., Harrison, Carol A., Basen-Engquist, Karen M.
Publicado em 2011

Cardiac mechanics and dysfunction with anthracyclines in the community: results from the PREDICT study

Por Narayan, Hari K, Wei, Wei, Feng, Ziding, Lenihan, Daniel, Plappert, Ted, Englefield, Virginia, Fisch, Michael, Ky, Bonnie
Publicado no Open Heart (2017)

An International Survey of Health Care Providers Involved in the Management of Cancer Patients Exposed to Cardiotoxic Therapy

Por Sulpher, Jeffrey, Mathur, Shrey, Lenihan, Daniel, Johnson, Christopher, Turek, Michele, Law, Angeline, Stadnick, Ellamae, Dattilo, Franco, Graham, Nadine, Dent, Susan F
Publicado no J Oncol (2015)

Rare Incidence of Congestive Heart Failure in Gastrointestinal Stromal Tumor and Other Sarcoma Patients Receiving Imatinib Mesylate (IM)

Por Trent, Jonathan C., Patel, Shalin S., Zhang, Jianhu, Araujo, Dejka M., Plana, Juan-Carlos, Lenihan, Daniel J., Fan, Dominic, Patel, Shreyaskumar R., Benjamin, Robert S., Khakoo, Aarif Y.
Publicado no Cancer (2010)

Cancer Therapy-Related Cardiac Dysfunction and Heart Failure Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging

Por Bloom, Michelle W., Hamo, Carine E., Cardinale, Daniela, Ky, Bonnie, Nohria, Anju, Baer, Lea, Skopicki, Hal, Lenihan, Daniel J., Gheorghiade, Mihai, Lyon, Alexander R., Butler, Javed
Publicado no Circ Heart Fail (2016)

Cancer Therapy-Related Cardiac Dysfunction and Heart Failure Part 2: Prevention, Treatment, Guidelines, and Future Directions

Por Hamo, Carine E., Bloom, Michelle W., Cardinale, Daniela, Ky, Bonnie, Nohria, Anju, Baer, Lea, Skopicki, Hal, Lenihan, Daniel J., Gheorghiade, Mihai, Lyon, Alexander R., Butler, Javed
Publicado no Circ Heart Fail (2016)

Glucose as a prognostic factor in ovarian carcinoma

Por Lamkin, Donald M., Spitz, Douglas R., Shahzad, Mian M. K., Zimmerman, Bridget, Lenihan, Daniel J., DeGeest, Koen, Lubaroff, David M., Shinn, Eileen H., Sood, Anil K., Lutgendorf, Susan K.
Publicado em 2009

Circulating Neuregulin During the Transition from Stage A to Stage B/C Heart Failure – A Breast Cancer Cohort

Por Geisberg, Carrie A., Abdallah, Wissam M., da Silva, Monica, Silverstein, Cheri, Smith, Holly M., Abramson, Vandana, Mayer, Ingrid, Means-Powell, Julie, Freehardt, Darla, White, Brenda, Lenihan, Daniel, Sawyer, Douglas B.
Publicado em 2013

INSTITUTIONAL VOLUME OF HEART TRANSPLANTATION WITH LEFT VENTRICULAR ASSIST DEVICE EXPLANTATION INFLUENCES GRAFT SURVIVAL

Por Haglund, Nicholas A, Feurer, Irene D, Ahmad, Rashid M, DiSalvo, Thomas G, Lenihan, Daniel J, Keebler, Mary E, Schlendorf, Kelly H, Stulak, John M, Wigger, Mark A, Maltais, Simon
Publicado em 2014

Sympathetic nervous system alterations with HER2+ antagonism: an early marker of cardiac dysfunction with breast cancer treatment?

Por Lenneman, Carrie G, Abdallah, Wissam M, Smith, Holly M, Abramson, Vandana, Mayer, Ingrid A, Silverstein, Cheri, Silverstein, Cheri, Means-Powell, Julie, Paranjape, Sachin Y, Lenihan, Daniel, Sawyer, Douglas B, Raj, Satish R
Publicado em 2014